Positive but very early news about a new immunotherapy drug for GBM has made the headlines today.
An initial study suggests that an experimental drug could be effective in treating patients with glioblastoma (GBM). Durvalumab, a drug used to fight other kinds of cancer, is being tested on 148 [...]